BCL2 and cancer: Interestingly, mutation rates in apoptotic proteins such as death receptors (Lee et al, 2001) or BCL-2 proteins (Kim et al, 2012) are low indicating that many cancer cells have intact apoptotic machinery which if unblocked could efficiently kill tumour cells.